BELIMUMAB

32030 reported adverse events

Drug classes: B Lymphocyte Stimulator-specific Inhibitor [EPC]

These side effects are most commonly reported by patients taking BELIMUMAB:

# Side effect Count
0 PRODUCT DOSE OMISSION ISSUE 5154
1 SYSTEMIC LUPUS ERYTHEMATOSUS 3979
2 FATIGUE 2095
3 DRUG INEFFECTIVE 1857
4 PAIN 1776
5 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1635
6 HEADACHE 1593
7 NAUSEA 1526
8 MALAISE 1425
9 PRODUCT COMPLAINT 1411
See all common reactions for BELIMUMAB

BELIMUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTINUCLEAR ANTIBODY NEGATIVE 17 0.4857
1 LUPUS ENTERITIS 19 0.3220
2 SLE ARTHRITIS 85 0.2993
3 PERICARDITIS LUPUS 11 0.2750
4 LUPUS PNEUMONITIS 26 0.2321
5 LUPUS NEPHRITIS 420 0.2244
6 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 25 0.2000
7 LUPUS ENDOCARDITIS 12 0.1967
8 CENTRAL NERVOUS SYSTEM LUPUS 43 0.1928
9 COMPLEMENT FACTOR INCREASED 14 0.1667
See all enriched reactions for BELIMUMAB